Enhancement of anti-murine colon cancer immunity by fusion of a SARS fragment to a low-immunogenic carcinoembryonic antigen

Enhancement of anti-murine colon cancer immunity by fusion of a SARS fragment to a low-immunogenic carcinoembryonic antigen

<p>Abstract</p> <p>Background</p> <p>It is widely understood that tumor cells express tumor-associated antigens (TAAs), of which many are usually in low immunogenicity; for example, carcinoembryonic antigen (CEA) is specifically expressed on human colon cancer cells and...

Full description

Bibliographic Details
Main Authors: Lin Chen-Si, Kao Shih-Han, Chen Yu-Cheng, Li Chi-Han, Hsieh Yuan-Ting, Yang Shang-Chih, Wu Chang-Jer, Lee Ru-Ping, Liao Kuang-Wen
Format: Article
Language:English
Published: BMC 2012-02-01
Series:Biological Procedures Online
Subjects:
immunotherapy
tumor-derived peptide
tumor vaccine
low-immunogenicity
Online Access:http://www.biologicalproceduresonline.com/content/14/1/2

Internet

http://www.biologicalproceduresonline.com/content/14/1/2

Similar Items